期刊文献+

EGCG对肾小管上皮细胞转分化过程中MMP9与Cyclin D1表达的影响及意义 被引量:2

Effects of EGCG on expression of MMP9 and cyclin D1 in the transdifferentiation of renal tubular epithelial cell and its significance
暂未订购
导出
摘要 目的探讨表没食子儿茶素没食子酸酯(EGCG)对肾小管上皮细胞转分化的作用机制。方法培养大鼠肾小管上皮细胞株NRK-52E,将其分成4组。1组:正常对照组(N),以DMEM培养液为空白对照。2组:转化生长因子(TGF-β1)诱导组;3组:EGCG200μg/L干预组;4组:EGCG400μg/L干预组。各细胞组在作用48 h后,应用免疫组化检测平滑肌肌动蛋白(α-SMA)和角蛋白(CK-18),Western-blot分析胞浆蛋白细胞周期素D1(Cyclin D1)、基质金属蛋白酶9(MMP9)含量,实时荧光定量PCR法测Cyclin D1、MMP9mRNA的相对表达量。结果 NRK细胞被TGF-β1诱导48 h后,胞浆中出现α-SMA蛋白高表达,CK-18蛋白表达明显减少;Cyclin D1、MMP9蛋白及其mRNA出现了高表达;EGCG干预组上述改变明显减轻。结论 EGCG以剂量依赖方式抑制TGF-β1诱导的NRK细胞的转分化,其机制可能是通过抑制Cyclin D1、MMP9蛋白及mRNA表达而实现的。 Objective To explore the effect and mechanism of epigallocatechin-3-gallate(EGCG)on the transdifferentiation of renal tubular epithelial cells.Methods Tubular epithelial cell of rat(NRK-52E)was cultured and then were divided into four groups.Group one:Normal control(N),Group two:TGF-β1 induction group,Group three:200 μg/L EGCG experimental group,Group four:400 μg/L EGCG experimental group.The protein expression of α-SMA,CK-18 were detected by immunostaining,cyclin D1,MMP9 were detected by Western-blotting,and the mRNA expression of cyclin D1,MMP9 from cell line were detected by real-time PCR at 48 hours after treatment.Results When the NRK cells were induced by TGF-β1 for 48 hours,the cytoplasmic protein α-SMA began expression and the expression of CK-18 reduced,the protein and mRNA expression of cyclin D1,MMP9 were up-regulated,such changes in the EGCG group were slight.Conclusion EGCG can inhibit the transdifferentiation induced by TGF-β1 of NRK cells in a concentration-dependent manner.The mechanism may be the inhibition of protein and mRNA expression of MMP9 and cyclin D1.
出处 《实用药物与临床》 CAS 2011年第3期185-188,共4页 Practical Pharmacy and Clinical Remedies
基金 沈阳市科学技术计划项目(F10-205-1-29) 中国医科大学附属盛京医院科研基金
关键词 上皮细胞转分化 EGCG 转化生长因子 细胞周期素(cyclin)D1 基质金属蛋白酶9(MMP9) Epithelial-mesenchymal transition Epigallocatechin-3-gallate(EGCG) Transforming growth factor-β1 Cyclin D1 Matrix metalloproteinase(MMP9)
  • 相关文献

参考文献22

  • 1Liu Y.New insights into epithelial-mescnchymal transition in kidney fibrosis[J].J Am Soc Nephrol,2010,21(2):212-222.
  • 2Liu Y.Epithelial to mesenchymal transition in renal fibrogenesis pathologic significance molecularmechanism,and therapeutic intervention[J].J AM Soc Nephrol,2004,15(1):1-12.
  • 3Sebe A,Leivonen SK,Fintha A,et al.Transforming growth factor-beta-induced alpha-smooth muscle cell actin expression in renal proximal tubolar cells is regulated by p38beta mitogen-activated protein kinase,extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial-myofibroblast transdifferentiation[J].Nepbrol Dial Transplant,2008,23(5):1537-1545.
  • 4Nakamuta M,Higashi N,Kohjima M,et al.Epigallocatechin-3-gallate,a polyphenol component of green tea,suppresses both collagen production and collagenase activity in hepatic stellate cells[J].Int J Mol Med,2005,16(4):677-681.
  • 5Zhen MC,Wang Q,Huang XH,et al.Green tea polyphenol epigalllocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachlorideinduced hepatic fibrosis[J].J Nutr Biochem,2007,18(12):795-805.
  • 6Fu YM,Zhou YJ,Zheng SZ,et al.The antifibrogenic effect of(-)-epigellocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells[J].Lab Invest,2006,86:697-709.
  • 7Garcia-Sanchez O,L6pez-Heroandez FJ,L6pez-Novoa JM.An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease[J].Kidney Int,2010,77(11):950-955.
  • 8Zeisberg M,Duffield JS.Resolved:EMT produces fibroblasts in the kidney[J].J Am Soc Nephrol,2010,21(8):1247-1253.
  • 9Rastaldi MP.Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis[J].J Nephrol,2006,19(4):407-412.
  • 10Kovesi G,Szende B.Prognostic value of cyclin D1,p27,and p63 in oral lenkoplakia[J].J Oral Pathol Med,2006,35(5):274-277.

二级参考文献40

  • 1JIANGWei WANGJi-yao YANGChang-qing LIUWen-bin WANGYi-qing HEBo-ming.Effects of a plasmid expressing antisense tissue inhibitor of metalloproteinase-1 on liver fibrosis in rats[J].Chinese Medical Journal,2005(3):192-197. 被引量:21
  • 2Yu-MeiZhang Xiang-MeiChen DiWu Suo-ZhuShi ZhongYin RuiDing YangLü.Expression of tissue inhibitor of matrix metalloproteinases-1 during aging in rat liver[J].World Journal of Gastroenterology,2005,11(24):3696-3700. 被引量:4
  • 3杨彤涛,牛子长,李存孝,黄立军,高杰,马保安,范清宇,周勇.表没食子儿茶素-3-没食子酸酯抑制骨肉瘤细胞增殖及其机制[J].实用医学杂志,2007,23(10):1449-1451. 被引量:7
  • 4Matsumoto K, Nakamura T. Renotropic role and therapeutic potential of HGF in the kidney[J]. Nephrol Dial Transplant,2002, 17(Suppl 9) :59 - 61.
  • 5Eddy AA. Molecular basis of renal fibrosis [J ]. Pediatr Nephrol, 2000, 15(3 - 4): 290 - 301.
  • 6ZaouiP, CantinJF, Alimardani-Bessette M, etal. Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions[J]. Diabetes Metab, 2000, 26(Suppl 4): 25 - 29.
  • 7Rerolle JP, Hertig A, Nguyen G, et al. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis[J].Kidney Int, 2000, 58(5): 1841 - 1850.
  • 8Oda T, Jung YO, Kim HS, et al. PAI- 1 deficiency attenuates the fibrogenic response to ureteral obstruction[J]. Kidney Int, 2001, 60(2): 587-596.
  • 9Datta PK, Blake MC, Moses HL. Regulation of plasminogen activator inhibitor- 1 expression by transfomfing growth factor- beta - induced physical and functional interactions between smads and Sp1[J]. J Biol Chem, 2000, 275(51): 40014-40019.
  • 10Dennler S, Itoh S, Vivien D, et al. Direct binding of Smad3and Smad4 to critical TGF beta - inducible elements in the promoter of human plasminogen activator inhibitor- type 1gene[J]. EMBO J, 1998, 17(11): 3091-3100.

共引文献42

同被引文献26

  • 1Zhang QW, Liu L, Chen R, et al. Matrix metalloproteinase-9 as a prognostic factor in gastric cancer- a meta-analysis. Asian Pac J Cancer Prey, 2012,13 ( 6 ) :2903-2908.
  • 2Chien MH, Lin CW, Cheng CW, et al. Matrix metalloproteinase- 2 as a target for head and neck cancer therapy. Expert Opin Ther Targets, 2013,17 ( 2 ) : 203-216. doi : 10. 1517/14728222.2013. 740012.
  • 3Di Carlo A. Matrix metalloproteinase-2 and -9 in the sera and in the urine of human oneocytoma and renal cell carcinoma. Oncol Rep, 2012,28 ( 3 ) : 1051 - 1056. doi : 10.3892/ar. 2012.1864.
  • 4Aromdee C. Modificalions of andrographolide to increase some bio- logical activities: a patent review (2006 - 2011 ). Expert Opin T- her Pat,2012,22(2) :169-180. doi: 10.1517/13543776.2012. 661718.
  • 5Pratheeshkumar P, Kuttan G. Andrographolide inhibits human mn- bilical vein endothelial cell invasion and migration by regulating MMP-2 and MMP-9 (luring angiogenesis. J Environ Pathol Toxicol Onco1,2011,30( 1 ) :33-41.
  • 6Santos AA, Lopes CC, Marques RM, et al. Matrix metalloprotein- ase-9 expression in mammary gland tumors in dogs and its relation- ship with prognostic factors and patient outcome. Am J Vet Res, 2012,73(5 ) :689-697. doi: 10. 2460/ajvr. 73.5. 689.
  • 7Gabelloni P, Da Pozzo E, Bendinelli S, et al. Inhibition of metal- loproteinases derived from tmnours: new insights in the treatment of human glioblastoma. Neuroscience, 2010, 168 ( 2 ) : 514-522. doi: 10. 1016/j. neumscience. 2010.03. 064.
  • 8Zhou J,Zhang ZX, Zhao H, et al. Anti-angiogenesis by lentivirus- mediated small interfering RNA silencing of angiopoietin-2 gene in pancreatic carcinoma. Teehnol Cancer Res Treat, 2011,10 ( 4 ) : 361-369.
  • 9Nateewattana J,Saeeng R, Kasemsook S, et al. Inhibition of topni- somerase Ⅱ α activity and induction of apnptosis in mammalian cells by semi-synthetic andrographolide analogues. Invest New Drugs,2013,31 (2) :320-332. doi : 10. 1007/s106374312-9868-9.
  • 10Jannin B, Menzel M, Berlot JP, et al. Transport of resveratrol,a cancer chemopreventive agent, to cellular targets : plasmatic protein binding and cell uptake. Biochem Phannaco1,2004,68 (6) :1113-1118.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部